Sumaq Life LLC is currently working with research partners at Texas A&M University to develop an explainable AI approach to design personalized cancer treatment. Explainable AI uses models of complex gene regulatory networks involved in cancer development to target therapy with a better likelihood of success.
These models have been used to identify key drug targets that have demonstrated remarkable success in achieving robust cancer cell killing in several aggressive cancer cell lines, including metastatic melanoma 1 , osteosarcoma 2 , breast 3 , pancreatic 4 , lung 5 , and colorectal 6 cancer.
Sumaq Life was formed to create health-related technological innovations and increase translation of scientific discoveries into real-world applications.